Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Enzo Biochem, Inc. (ENZ) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Enzo Biochem, Inc. (ENZ) - free report >>
Image: Bigstock
New Strong Buy Stocks for July 11th
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:
• Acuity Brands, Inc. (AYI - Free Report) produces and distributes lighting solutions and services for commercial, institutional, industrial, infrastructure and residential applications in North America and across the globe. The Zacks Consensus Estimate for its current year earnings has improved by 0.3% over the last 30 days.
• Carter's, Inc. (CRI - Free Report) design, source and market branded childrenswear under the Carters, Child of Mine, Just One You, Precious Firsts, Oshkosh and other brands. The Zacks Consensus Estimate for its current year earnings has gained by 0.1% over the last 30 days.
• CDK Global, Inc. provides integrated information technology and digital marketing/advertising solutions to the automotive retail industry worldwide. It has seen the Zacks Consensus Estimate for its current year earnings increase 1.5% over the last 30 days.
• Diplomat Pharmacy, Inc. operates as an independent specialty pharmacy in the United States. The Zacks Consensus Estimate revision for its current year earnings was a positive 0.1% over the last 30 days.
• Enzo Biochem Inc. (ENZ - Free Report) an integrated life sciences and biotechnology company that engages in the research, development and marketing of diagnostic and research products based on genetic engineering, biotechnology and molecular biology. The Zacks Consensus Estimate for its current year earnings has advanced 4.2% over the last 30 days.
View the entire Zacks Rank #1 List.